Skip to main content
OpenTrials
Recruiting

NCT Number: NCT01788592

Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry)

The objective of this study is to evaluate effectiveness and safety of drug-eluting stent implantation in the "real world" daily practice.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Coronary Artery Disease Arterial Occlusive Diseases Arteriosclerosis Cardiovascular Diseases Coronary Disease Heart Diseases Myocardial Ischemia Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • coronary disease amenable to percutaneous coronary intervention (PCI)
  • no clinical and lesion limitations

Exclusion criteria

  • patients with a mixture of several drug eluting stents
  • terminal illness with life expectancy less than 1 year
  • patients with cardiogenic shock

Treatment and study plan

Primary outcomes

  1. Major Adverse Cardiac Event

    Time frame: 1year

    Death from any causes, myocardial infarction or any repeat revascularization

Secondary outcomes

  1. all cause Death

    Time frame: 1year

  2. Myocardial Infarction

    Time frame: 1year

  3. The composite of Death or myocardial infarction

    Time frame: 1year

  4. Any repeat revascularization

    Time frame: 1year

  5. Target vessel revascularization

    Time frame: 1year

  6. Target lesion revascularization

    Time frame: 1year

  7. New lesion revascularization

    Time frame: 1year

  8. Stent thrombosis by Academic Research Consortium criteria

    Time frame: 1year

Sponsors and collaborators

Lead sponsor

Seung-Jung Park

Other

Registry information

Official study title

Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice

Important dates

Study start
2003
Primary completion
2030
Study completion
2030
First posted
Feb 11, 2013
Registry last updated
Jan 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.